scholarly article | Q13442814 |
P50 | author | Tomasz Guzik | Q7818402 |
Eilidh McGinnigle | Q125264720 | ||
Ryszard Nosalski | Q125264818 | ||
Mateusz Siedlinski | Q58331270 | ||
P2860 | cites work | Statin Therapy in Metabolic Syndrome and Hypertension Post-JUPITER: What is the Value of CRP? | Q24602803 |
Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system | Q24655588 | ||
Requirement of bic/microRNA-155 for normal immune function | Q24656120 | ||
Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes | Q24678210 | ||
MicroRNA-155 is induced during the macrophage inflammatory response | Q24683841 | ||
Acute blood pressure responses in healthy adults during controlled air pollution exposures | Q24815292 | ||
Adipocytes, aldosterone and obesity-related hypertension | Q26746054 | ||
Macrophages in vascular inflammation--From atherosclerosis to vasculitis | Q26825052 | ||
Antibodies in the pathogenesis of hypertension | Q26828588 | ||
Role of the NADPH oxidases in the subfornical organ in angiotensin II-induced hypertension | Q42117572 | ||
Effects of Obesity on Perivascular Adipose Tissue Vasorelaxant Function: Nitric Oxide, Inflammation and Elevated Systemic Blood Pressure | Q42203971 | ||
Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension | Q42593944 | ||
Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension | Q42703902 | ||
Renal transporter activation during angiotensin-II hypertension is blunted in interferon-γ-/- and interleukin-17A-/- mice | Q42863966 | ||
Association of interleukin-6, interleukin-12, and interleukin-10 gene polymorphisms with essential hypertension in Tatars from Russia | Q43477683 | ||
Interleukin-10 reduces inflammation, endothelial dysfunction, and blood pressure in hypertensive pregnant rats | Q43980004 | ||
Immunosenescent CD8+ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension. | Q44022821 | ||
Angiotensin II-induced vascular dysfunction depends on interferon-γ-driven immune cell recruitment and mutual activation of monocytes and NK-cells. | Q44119832 | ||
Functional role of NF-κB in expression of human endothelial nitric oxide synthase | Q44398371 | ||
Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein | Q44477046 | ||
One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. | Q44552484 | ||
Relationship of plasma interleukin-6 and its genetic variants with hypertension in Hong Kong Chinese | Q44884504 | ||
Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats | Q44895722 | ||
Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease | Q44984910 | ||
C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase | Q45271914 | ||
Lowering of blood pressure leads to decreased circulating interleukin-6 in hypertensive subjects | Q46368521 | ||
Macrophages come to mind as keys to cognitive decline | Q46423522 | ||
The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem | Q46570585 | ||
Superoxide dismutase activity and expression in human venous and arterial bypass graft vessels. | Q46573053 | ||
Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular inju | Q46650169 | ||
Effects of angiotensin II receptor blockade with valsartan on pro-inflammatory cytokines in patients with essential hypertension | Q46819084 | ||
Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease | Q46822082 | ||
IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy | Q46930205 | ||
Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis. | Q47104825 | ||
Role of innate and adaptive immunity in obesity-associated metabolic disease | Q49850396 | ||
The burden of adult hypertension in the United States 1999 to 2000: a rising tide | Q50143429 | ||
Combination of IL-17 and TNFα induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells | Q83278153 | ||
T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury | Q83288251 | ||
Interleukin 10 deficiency exacerbates toll-like receptor 3-induced preeclampsia-like symptoms in mice | Q84570494 | ||
Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase | Q85309830 | ||
[Endothelial dysfunction related to oxidative stress and inflammation in perivascular adipose tissue] | Q85618099 | ||
Endothelial function assessment in atherosclerosis: comparison of brachial artery flow‑mediated vasodilation and peripheral arterial tonometry | Q85732769 | ||
Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes | Q87091235 | ||
Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis | Q87230887 | ||
Toll-like receptors and hypertension | Q27004654 | ||
Immune activation caused by vascular oxidation promotes fibrosis and hypertension | Q27332212 | ||
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 | ||
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts | Q28511032 | ||
Genome-wide association study of blood pressure and hypertension | Q28943443 | ||
Regulation of the germinal center response by microRNA-155 | Q29547777 | ||
How regulatory T cells work | Q29614262 | ||
The regulation of IL-10 production by immune cells | Q29615479 | ||
Leukocyte-dependent responses of the microvasculature to chronic angiotensin II exposure | Q30528414 | ||
Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase. | Q30589228 | ||
Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor | Q30747560 | ||
NADPH oxidases in vascular pathology | Q33632089 | ||
Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction | Q33642021 | ||
T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats | Q33784344 | ||
Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction | Q33817996 | ||
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. | Q33898507 | ||
C/EBP transcription factors regulate NADPH oxidase in human aortic smooth muscle cells | Q34011539 | ||
Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. | Q34081023 | ||
MicroRNA-155 regulates angiotensin II type 1 receptor expression and phenotypic differentiation in vascular adventitial fibroblasts | Q34132935 | ||
Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives. | Q34145150 | ||
Tumor necrosis factor-alpha g308α gene polymorphism and essential hypertension: a meta-analysis involving 2244 participants | Q34247252 | ||
T cell-dependent B cell activation | Q34363600 | ||
DC isoketal-modified proteins activate T cells and promote hypertension. | Q34454645 | ||
Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug | Q34487872 | ||
Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice | Q34756142 | ||
Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis | Q34766857 | ||
Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression | Q34978708 | ||
Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation | Q34986033 | ||
The immune system and hypertension. | Q35038155 | ||
IL-10 inhibits the NF-κB and ERK/MAPK-mediated production of pro-inflammatory mediators by up-regulation of SOCS-3 in Trypanosoma cruzi-infected cardiomyocytes | Q35048439 | ||
Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice | Q35050827 | ||
Interferon-gamma induces Fas trafficking and sensitization to apoptosis in vascular smooth muscle cells via a PI3K- and Akt-dependent mechanism | Q35088374 | ||
MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis | Q35091092 | ||
Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation | Q35183974 | ||
Endothelial NADPH oxidases: which NOX to target in vascular disease? | Q38234422 | ||
Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression | Q38334975 | ||
TNF-alpha induces a decrease in eNOS promoter activity | Q38349351 | ||
Interleukin-10 induction of nitric-oxide synthase expression attenuates CD40-mediated interleukin-12 synthesis in human endothelial cells | Q38352602 | ||
Role of Inflammation and Immunity in Hypertension: Recent Epidemiological, Laboratory, and Clinical Evidence | Q38723456 | ||
The role of miRNAs in cardiovascular disease risk factors | Q38815760 | ||
Associations of Short-Term and Long-Term Exposure to Ambient Air Pollutants With Hypertension: A Systematic Review and Meta-Analysis | Q38849162 | ||
Obligatory Role for B Cells in the Development of Angiotensin II-Dependent Hypertension | Q38966025 | ||
M2 macrophage accumulation in the aortic wall during angiotensin II infusion in mice is associated with fibrosis, elastin loss, and elevated blood pressure. | Q38996054 | ||
miR-10b-5p is a novel Th17 regulator present in Th17 cells from ankylosing spondylitis. | Q39049032 | ||
Perivascular adipose tissue inflammation in vascular disease | Q39072710 | ||
Dual role of miR-21 in CD4+ T-cells: activation-induced miR-21 supports survival of memory T-cells and regulates CCR7 expression in naive T-cells | Q39085506 | ||
CD45RO+ memory T-cells produce IL-17 in patients with atherosclerosis | Q40211705 | ||
Hypertensive response to acute stress is attenuated in interleukin-6 knockout mice | Q40491900 | ||
Hypertrophic and antihypertrophic microRNA levels in peripheral blood mononuclear cells and their relationship to left ventricular hypertrophy in patients with essential hypertension | Q40551864 | ||
Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-α Is Mediated by CCAAT/Enhancer-binding Protein Family Members | Q40619563 | ||
Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I study. | Q40812995 | ||
MicroRNA-155 modulates the proliferation of vascular smooth muscle cells by targeting endothelial nitric oxide synthase | Q41075048 | ||
Transfer of arterial hypertension by splenic cells from DOCA-salt hypertensive and renal hypertensive rats to normotensive recipients | Q41643789 | ||
Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) Working Groups "Atherosclerosis & Vascular Biology" and "Thrombosis". | Q50590519 | ||
Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension. | Q51013382 | ||
MiR-338-5p Promotes Inflammatory Response of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis via Targeting SPRY1. | Q51184630 | ||
Interferon-γ signaling inhibition ameliorates angiotensin II-induced cardiac damage. | Q52886251 | ||
Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. | Q52959125 | ||
Circulating miR-21 and eNOS in subclinical atherosclerosis in patients with hypertension. | Q54158544 | ||
Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction. | Q54351740 | ||
Regulation of T lymphocyte activation by microRNA-21. | Q54368377 | ||
Primary role of renal homografts in setting chronic blood pressure levels in rats | Q54625890 | ||
Interferon-gamma induces human vascular smooth muscle cell proliferation and intimal expansion by phosphatidylinositol 3-kinase dependent mammalian target of rapamycin raptor complex 1 activation. | Q55044239 | ||
Strain-dependent susceptibility for hypertension in mice resides in the natural killer gene complex | Q58820736 | ||
Toll-Like Receptor 4 Mediates Maladaptive Left Ventricular Remodeling and Impairs Cardiac Function After Myocardial Infarction | Q59981285 | ||
Reversal of Vascular Macrophage Accumulation and Hypertension by a CCR2 Antagonist in Deoxycorticosterone/Salt-Treated Mice | Q62393703 | ||
Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice? | Q63915080 | ||
Evidence for an initial, thymus independent and a chronic, thymus dependent phase of DOCA and salt hypertension in mice | Q67874685 | ||
Remission of essential hypertension after renal transplantation | Q70284600 | ||
Passive transfer of autoimmune induced hypertension in the rat by lymph node cells | Q72258313 | ||
Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease | Q74232819 | ||
Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries | Q75303272 | ||
AUTOIMMUNE FACTORS ASSOCIATED WITH INFARCTION OF THE KIDNEY | Q77163201 | ||
Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism | Q79249916 | ||
Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis | Q79386445 | ||
C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice | Q79731225 | ||
Interleukin-10 counteracts impaired endothelium-dependent relaxation induced by ANG II in murine aortic rings | Q79830754 | ||
Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients | Q81543046 | ||
[Differential expression of microRNAs in the aorta of spontaneously hypertensive rats] | Q81761619 | ||
Immune regulation and vascular inflammation in genetic hypertension | Q82377791 | ||
T regulatory lymphocytes prevent aldosterone-induced vascular injury | Q82831987 | ||
IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation | Q83187595 | ||
Lymphocyte responses exacerbate angiotensin II-dependent hypertension | Q35576468 | ||
IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate? | Q35581520 | ||
IL-10-producing intestinal macrophages prevent excessive antibacterial innate immunity by limiting IL-23 synthesis | Q35597423 | ||
Reducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in Vascular Remodeling and Inflammation | Q35649420 | ||
Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice | Q35673271 | ||
Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells | Q35913007 | ||
Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo | Q35928298 | ||
T lymphocytes and vascular inflammation contribute to stress-dependent hypertension. | Q35965607 | ||
Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction | Q36229028 | ||
Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation | Q36406495 | ||
The role of type 1 angiotensin receptors on T lymphocytes in cardiovascular and renal diseases | Q36532932 | ||
Interleukin-10 released by CD4(+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice | Q36607837 | ||
Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension | Q36641593 | ||
Genetic mutation of recombination activating gene 1 in Dahl salt-sensitive rats attenuates hypertension and renal damage | Q36700283 | ||
Hypertension in metabolic syndrome: vascular pathophysiology. | Q36737819 | ||
Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension. | Q36812077 | ||
Activation of Human T Cells in Hypertension: Studies of Humanized Mice and Hypertensive Humans | Q36989415 | ||
Circulating neutrophils maintain physiological blood pressure by suppressing bacteria and IFNgamma-dependent iNOS expression in the vasculature of healthy mice. | Q37014315 | ||
Regulation of T-cell function by endogenously produced angiotensin II. | Q37100479 | ||
Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review | Q37194034 | ||
Cardiovascular effects of air pollution | Q37240041 | ||
CREB-mediated IL-6 expression is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration | Q37299808 | ||
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis | Q37315021 | ||
Role of Tumor Necrosis Factor-α and Natural Killer Cells in Uterine Artery Function and Pregnancy Outcome in the Stroke-Prone Spontaneously Hypertensive Rat. | Q37327354 | ||
Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy | Q37330943 | ||
Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity. | Q37354248 | ||
C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling | Q37408109 | ||
Effect of psychological stress on blood pressure increase: a meta-analysis of cohort studies. | Q37433900 | ||
Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives | Q37590008 | ||
Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats | Q37731722 | ||
Under pressure: the search for the essential mechanisms of hypertension | Q37953776 | ||
Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies | Q38019997 | ||
Reactive oxygen species production in the phagosome: impact on antigen presentation in dendritic cells | Q38029097 | ||
Angiotensin II and vascular injury | Q38206728 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 4 | |
P921 | main subject | arterial hypertension | Q41861 |
P304 | page(s) | 12 | |
P577 | publication date | 2017-03-06 | |
P1433 | published in | Journal of Cardiovascular Risk | Q27723050 |
P1476 | title | Novel Immune Mechanisms in Hypertension and Cardiovascular Risk | |
P478 | volume | 11 |
Q64057181 | Context-Dependent Effect of Glucocorticoids on the Proliferation, Differentiation, and Apoptosis of Regulatory T Cells: A Review of the Empirical Evidence and Clinical Applications |
Q47195395 | Genetic and Environmental Effects on Gene Expression Signatures of Blood Pressure: A Transcriptome-Wide Twin Study |
Q54980602 | Heterogenous treatment effects: secrets for a reliable treat-to-target trial? |
Q54060732 | Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases. |
Q64906046 | Inflammatory Signaling in Hypertension: Regulation of Adrenal Catecholamine Biosynthesis. |
Q38685111 | Interleukin-18 polymorphism as an inflammatory index in metabolic syndrome: A preliminary study. |
Q46269480 | Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets. |
Q64234882 | Proinflammatory Role of Angiotensin II in the Aorta of Normotensive Mice |
Q57295264 | Recent research progress of microRNAs in hypertension pathogenesis, with a focus on the roles of miRNAs in pulmonary arterial hypertension |
Q89451828 | Targeting toll-like receptor 4 signalling pathways: can therapeutics pay the toll for hypertension? |
Q47550084 | The association of high sensitivity C-reactive protein and incident Alzheimer disease in patients 60 years and older: The HUNT study, Norway |
Q62272072 | The emerging alliance of sphingosine-1-phosphate signalling and immune cells: from basic mechanisms to implications in hypertension |
Q38637700 | The role of infiltrating immune cells in dysfunctional adipose tissue. |
Search more.